A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer
Clinical trial NCT07042802 · RECRUITING
Trial details
- NCT number
- NCT07042802
- Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-02
- Primary completion
- 2027-12-25
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.